Elixinol Wellness Limited (ASX:EXL)
0.0110
-0.0010 (-8.33%)
Jan 8, 2026, 1:22 PM AEST
Elixinol Wellness Market Cap
Elixinol Wellness has a market cap or net worth of 4.55 million as of January 8, 2026. Its market cap has decreased by -41.62% in one year.
Market Cap
4.55M
Enterprise Value
6.57M
Revenue
15.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since January 8, 2018, Elixinol Wellness's market cap has decreased from 149.25M to 4.55M, a decrease of -96.95%. That is a compound annual growth rate of -35.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 4.97M | 33.33% |
| Dec 31, 2025 | 3.73M | -55.60% |
| Dec 31, 2024 | 8.39M | 10.49% |
| Dec 29, 2023 | 7.59M | 14.40% |
| Dec 30, 2022 | 6.64M | -70.81% |
| Dec 31, 2021 | 22.75M | -58.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 81.96B |
| Pro Medicus | 22.56B |
| Cochlear | 17.17B |
| Sonic Healthcare | 11.04B |
| Ramsay Health Care | 8.20B |
| Ansell | 5.07B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.50B |